Simplex Trading’s Acer Therapeutics Inc ACER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,945
Closed -$1K 10224
2023
Q3
$1K Buy
1,945
+499
+35% +$410 ﹤0.01% 8490
2023
Q2
$1K Sell
1,446
-1,472
-50% -$1.3K ﹤0.01% 8801
2023
Q1
$2K Sell
2,918
-8,234
-74% -$16.2K ﹤0.01% 8593
2022
Q4
$27K Sell
11,152
-1,725
-13% -$2.96K ﹤0.01% 6594
2022
Q3
$17K Buy
12,877
+10,186
+379% +$14.7K ﹤0.01% 7724
2022
Q2
$3K Buy
2,691
+2,449
+1,012% +$5.13K ﹤0.01% 9241
2022
Q1
$0 Buy
+242
New +$584 ﹤0.01% 11702
2021
Q4
Sell
-9,591
Closed -$22.3K 11730
2021
Q3
$27K Hold
9,591
﹤0.01% 8178
2021
Q2
$27K Sell
9,591
-7,091
-43% -$20.4K ﹤0.01% 8330
2021
Q1
$51K Buy
16,682
+15,851
+1,907% +$53.9K ﹤0.01% 6598
2020
Q4
$2K Buy
+831
New +$2.24K ﹤0.01% 8041

Other funds holding ACER

Simplex Trading's ACER Position: Q4 2023 in Review

Simplex Trading sold out of Acer Therapeutics Inc (ACER) in Q4 2023, closing a stake of 1,945 shares — an estimated $1K sold.

Simplex Trading first reported a position in ACER in Q4 2020 and held it in 11 quarters. The position peaked at $51K in Q1 2021. 2 funds tracked by Wall St. Rank hold ACER as of Q4 2023.

  • Simplex Trading reported no remaining Acer Therapeutics Inc position as of Q4 2023 after selling out during the quarter.
  • Simplex Trading sold 1,945 Acer Therapeutics Inc shares in Q4 2023, an estimated $1K.
  • Simplex Trading first reported a position in Acer Therapeutics Inc in Q4 2020 and held it in 11 quarters.
  • Simplex Trading's Acer Therapeutics Inc position peaked at $51K in Q1 2021.
  • 2 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q4 2023.

Based on Simplex Trading's 13F filing for Q4 2023, filed 2 Feb 2024.